1) M receptor antagonist
M受体拮抗剂
1.
Because many vital diseases such as Parkinsonian syndromes, Alzheimer's disease, chronic obstructive pulmonary disease(COPD) and irritable bowel syndrome are associated with M receptors, more and more attention has been paid to the research on M receptor antagonists.
许多重大疾病如帕金森氏综合症、早老性痴呆、慢性阻塞性肺病及应激性肠道综合症的发生均与M受体密切相关,M受体拮抗剂的研究是新药研究的重要方向。
2) M antagonist
M-受体拮抗剂
3) Receptor antagonist
受体拮抗剂
1.
Advances on leukotrienes and leukotriene receptor antagonists in asthma;
白三烯受体拮抗剂研究新进展
2.
Eplerenone——a new aldosterone receptor antagonist with cardiovascular protective effect;
对心血管具有保护作用的醛固酮受体拮抗剂依普利酮
3.
Anti-asthmatic effects of interleukin-1 receptor antagonist in sensitized guinea pigs;
白介素-1受体拮抗剂对致敏豚鼠的抗喘作用(英文)
4) 5-HT3 receptor antagonist
5-HT3受体拮抗剂
1.
Ondansetron Hydrochloride is a high effective and high selective 5-HT3 receptor antagonist and is used on anti-emesis after chemotherapy and radiotherapy and postoperation.
盐酸昂丹司琼（Ondansetron Hydrochloride）是一种高效，高选择性的5-HT3受体拮抗剂[1,2]，用于对抗癌症化学治疗和放射治疗引起的呕吐以及手术后的急性呕吐[3-5]。
5) AT1 receptor antagonist
AT1受体拮抗剂
1.
Objective To investigate the effects of AT1 receptor antagonist candesartan on acute pancreatitis(AP) of rats.
结论早期应用AT1受体拮抗剂坎地沙坦可以明显减轻大鼠胰腺的急性炎症病变及损伤。
6) NMDA receptor antagonist
NMDA受体拮抗剂
1.
objective The effect was investigated to induce NSC proliferation and differentiation in the adult rat SGZ、SVZ and cortex by NMDA receptor antagonist administration following focal ischemic insults produced by middle cerebral artery occlusion (MCAO).
结论 NMDA受体拮抗剂MK- 80 1在脑缺血后,能促进NSC的增殖、分化。
2.
Investigation of Internal Activating Neural Stem Cell by NMDA Receptor Antagonist Administration Following Focal Ischemic Insults;
结论:NMDA受体拮抗剂MK801在脑缺血后,能促进大鼠海马区NSCs的增殖、分化。
补充资料：钙拮抗剂
| 钙拮抗剂 calcium antagonists 主要通过阻断心肌和血管平滑肌细胞膜上的钙离子通道，抑制细胞外钙离子内流，使细胞内钙离子水平降低而引起心血管等组织器官功能改变的药物。临床常用的有硝苯吡啶、异搏定、硫氮唑酮等。对心脏的作用，主要是抑制心肌去极化过程中第二时相钙离子内流，降低细胞内钙，减弱心肌收缩力，降低心肌氧耗量，同时抑制窦房结和房室结的钙内流，使窦房结自律性下降，房室传导减慢，心室率降低，如异搏定，硫氮唑酮。在血管主要扩张动脉平滑肌，降低外周阻力，而对静脉平滑肌作用甚小，如硝苯吡啶。此类药物临床主要应用于高血压病、冠心病和心律失常。 |
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条